(UroToday.com) The 2024 Society of Urologic Oncology (SUO) annual meeting held in Dallas was host to the Bladder Cancer Course and the Session Non-Muscle Invasive Bladder Cancer (NMIBC). Dr. Liao ...

A randomized controlled trial found that carrageenan, a common food additive, may cause subclinical inflammation and insulin ...

A Huntington resident hospitalized last month due to West Nile virus, the 21st human case in Suffolk and at least the 41st on ...

(UroToday.com) The 2024 SUO annual meeting included a session on non muscle invasive bladder cancer, featuring a presentation by Dr. Ashish Kamat discussing BCG unresponsive cancer in 2024.

Preferably, your post run snack will also deliver a dose of polyphenols, Asche adds. These natural compounds are found in ...

Sarepta has acquired the global rights to develop ARO-DUX4 and ARO-DM1, two RNAi therapeutic candidates for types of muscular ...

TORINO, Italy I 03, 2024 I Resalis Therapeutics today announced the initiation of its first-in-human, Phase 1 study for RES-010, a non-coding ...

In preclinical studies, investigational ARO-ALK7 silenced Activin receptor-like kinase 7 (ALK7) expression in adipose tissue, which led to reduced body ...

Pathways to new treatments for heart failure take time—as long as four decades for two now accepted therapies. So, new ...

The American Red Cross Cell and Gene Therapy Solutions (CGTS) division, a leading single-source provider for allogeneic cell therapy source material, has selected Accellix, Inc., the developer of the ...

Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA) and Genethon, a pioneer and a leader in gene therapy research and dev ...